SEC Form 25-NSE filed by HEXO Corp.

6/22/23 5:20:40 PM ET

$HEXO

Pharmaceuticals and Biotechnology

Health Care

Get the next $HEXO alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38781

Issuer:	HEXO Corp.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	3000 Solandt Road
	Ottawa	ONTARIO, CANADA	K2K 2X2 CA
Telephone number:				819-743-3726

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common shares

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2023-06-22	By	Tara Petta		AVP
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $HEXO alert in real time by email

Recent Analyst Ratings for

$HEXO

Date	Price Target	Rating	Analyst
3/4/2022	$1.00 → $1.25	Hold → Speculative Buy	Canaccord Genuity
3/4/2022		Hold → Speculative Buy	Canaccord Genuity
3/4/2022	$1.20 → $0.90	Neutral	Cantor Fitzgerald
1/27/2022	$1.07 → $0.53	Underperform → Hold	Jefferies
12/15/2021	$2.00 → $0.80	Neutral → Underperformer	CIBC
12/15/2021		Neutral → Sector Underperform	CIBC
12/15/2021	$2.10 → $1.20	Neutral	Cantor Fitzgerald
10/29/2021	$2.29 → $2.10	Neutral	Cantor Fitzgerald

More analyst ratings

SEC Form 25-NSE filed by HEXO Corp.

6/22/23 5:20:40 PM ET

$HEXO

Pharmaceuticals and Biotechnology

Health Care

Get the next $HEXO alert in real time by email

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-38781

Issuer:	HEXO Corp.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	3000 Solandt Road
	Ottawa	ONTARIO, CANADA	K2K 2X2 CA
Telephone number:				819-743-3726

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common shares

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

2023-06-22	By	Tara Petta		AVP
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $HEXO alert in real time by email

Recent Analyst Ratings for

$HEXO

Date	Price Target	Rating	Analyst
3/4/2022	$1.00 → $1.25	Hold → Speculative Buy	Canaccord Genuity
3/4/2022		Hold → Speculative Buy	Canaccord Genuity
3/4/2022	$1.20 → $0.90	Neutral	Cantor Fitzgerald
1/27/2022	$1.07 → $0.53	Underperform → Hold	Jefferies
12/15/2021	$2.00 → $0.80	Neutral → Underperformer	CIBC
12/15/2021		Neutral → Sector Underperform	CIBC
12/15/2021	$2.10 → $1.20	Neutral	Cantor Fitzgerald
10/29/2021	$2.29 → $2.10	Neutral	Cantor Fitzgerald

More analyst ratings

SEC Form 25-NSE filed by HEXO Corp.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$HEXO

SEC Form 25-NSE filed by HEXO Corp.

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for
$HEXO

$HEXO
Press Releases

Fastest customizable press release news feed in the world

HEXO Corp. Announces Completion of Acquisition by Way of Arrangement With Tilray Brands, Inc.

HEXO Corp. Announces Receipt of Final Order for Arrangement With Tilray Brands, Inc.

HEXO Reports Q3'23 Financial Results

$HEXO
SEC Filings

SEC Form 15-12G filed by HEXO Corp.